Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Jun;87(12):4650-4.
doi: 10.1073/pnas.87.12.4650.

Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41

Affiliations

Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41

E O Freed et al. Proc Natl Acad Sci U S A. 1990 Jun.

Abstract

The human immunodeficiency virus transmembrane glycoprotein gp41 has at its amino terminus a strongly hydrophobic stretch of 28 amino acids flanked by a highly conserved series of polar amino acids. To investigate the role in syncytium formation of the hydrophobic amino terminus of gp41 and the polar border of this hydrophobic region, we introduced eight single-amino acid substitutions and one double-amino acid substitution in the amino-terminal 31 amino acids of gp41. The mutant envelope glycoproteins were expressed from two distinct human immunodeficiency virus type 1 envelope glycoprotein expression vectors; the effects of the mutations on syncytium formation, envelope glycoprotein transport, secretion, and CD4 receptor-binding were analyzed. Results showed that polar substitutions throughout the hydrophobic amino terminus of gp41 greatly reduced or blocked syncytium formation mediated by the human immunodeficiency virus type 1 envelope glycoproteins, as did nonconservative mutations in the polar border of the hydrophobic amino terminus. Mutations at gp41 amino acids 15, 26, and 29 also significantly increased the extent of gp120 secretion into the extracellular medium. None of the mutations detectably affected envelope glycoprotein processing or envelope glycoprotein binding to CD4.

PubMed Disclaimer

References

    1. Annu Rev Physiol. 1990;52:675-97 - PubMed
    1. J Virol. 1989 Nov;63(11):4670-5 - PubMed
    1. J Virol. 1969 Feb;3(2):126-32 - PubMed
    1. Proc Natl Acad Sci U S A. 1969 Oct;64(2):536-43 - PubMed
    1. Virology. 1970 Dec;42(4):1136-9 - PubMed

Publication types